Download PDF
Klin Monbl Augenheilkd 2019; 236(04): 384-390
DOI: 10.1055/a-0799-9700
Klinische Studie
Georg Thieme Verlag KG Stuttgart · New York

Visual Performance, Subjective Satisfaction and Quality of Life Effect of a New Refractive Intraocular Lens with Central Extended Depth of Focus

Visuelle Leistung, subjektive Zufriedenheit und Lebensqualität als Effekte einer neuen refraktiven Intraokularlinse mit zentraler erweiterter Tiefenschärfe
Kevin Gillmann
Glaucoma Research Centre, Montchoisi Clinic, Swiss Visio Network, Lausanne, Switzerland
,
André Mermoud
Glaucoma Research Centre, Montchoisi Clinic, Swiss Visio Network, Lausanne, Switzerland
› Author Affiliations
Further Information

Publication History

received 19 September 2018

accepted 13 November 2018

Publication Date:
14 February 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Purpose To assess the visual performance, clinical and quality of life outcomes, and subjective patient satisfaction after implantation of a new refractive/extended depth of focus (EDOF) hybrid intraocular lens (IOL).

Methods This is a monocentric, retrospective study of 29 patients (45 eyes), carried out in a tertiary care glaucoma research centre. All patients underwent implantation of a Lucidis (Swiss Advanced Vision, SAV-IOL SA, Neuchâtel, Switzerland) IOL during cataract surgery. Near, intermediate, and distance best-corrected visual acuities and uncorrected visual acuities were collected at baseline and 3 months postoperatively. Adverse events, contrast sensitivity, optical aberrations, subjective satisfaction, and spectacle independence were also analysed at 3 months.

Results At 3 months postoperatively, the mean photopic uncorrected monocular distance, and intermediate and near visual acuities were 0.2 logMAR (~ 20/32), 0.07 logMAR (~ 20/23), and 0.15 logMAR (~ 20/28), respectively. Mean best-corrected visual acuity was 0.05 logMAR (~ 20/23) for distance and 0.03 logMAR (~ 20/21) for near vision. Mean photopic contrast sensitivity was 1.5 log. The mean root mean square (RMS) was 0.119 ± 0.05 µm. Subjectively, over the 3-month follow-up, 9% of patients (n = 4) complained of halos, and 2% (n = 1) of photophobia. No other adverse events were noted.

Conclusions The Lucidis IOL demonstrates a good safety profile, with an acceptably low complication rate. While the uncorrected visual performance of this new optical design is inferior to that of other EDOF IOLs for distance vision, it achieves better results in intermediate and near vision, with consistently near-normal contrast sensitivity. Interestingly, self-reported spectacle independence and subjective patient satisfaction were high for all distances.

Zusammenfassung

Zweck Beurteilung der visuellen Leistung, der klinischen Ergebnisse und der Lebensqualität sowie der subjektiven Patientenzufriedenheit nach der Implantation einer neuen refraktiven/erweiterten Tiefenschärfe-Hybridintraokularlinse (EDOF-IOL).

Methoden Dies ist eine monozentrische, retrospektive Studie mit 29 Patienten (45 Augen), die in einem Tertiärpflegeglaukomforschungszentrum durchgeführt wurde. Alle Patienten wurden während einer Kataraktoperation mit einer Lucidis-Implantation (Swiss Advanced Vision, SAV-IOL SA, Neuenburg, Schweiz) implantiert. Nah-, mittel- und entfernungsabhängig am besten korrigierte Sehschärfe und unkorrigierte Sehschärfe wurden zu Beginn und 3 Monate nach der Operation erfasst. Unerwünschte Ereignisse, Kontrastempfindlichkeit, optische Aberrationen, subjektive Zufriedenheit und Brillenunabhängigkeit wurden ebenfalls nach 3 Monaten analysiert.

Ergebnisse Drei Monate postoperativ betrugen der mittlere photopische unkorrigierte monokulare Abstand und die mittlere und nahe visuelle Schärfe 0,2 logMAR (~ 20/32), 0,07 logMAR (~ 20/23) bzw. 0,15 logMAR (~ 20/28). Die mittlere, am besten korrigierte Sehschärfe betrug 0,05 logMAR (~ 20/23) für die Entfernung und 0,03 logMAR (~ 20/21) für die Nahsicht. Die mittlere photopische Kontrastempfindlichkeit betrug 1,5 log. Der mittlere quadratische Mittelwert (RMS) betrug 0,119 ± 0,05 µm. Subjektiv klagten 9% der Patienten (n = 4) im Verlauf des 3-monatigen Follow-ups über Halos und 2% (n = 1) über Photophobie. Es wurden keine anderen nachteiligen Ereignisse festgestellt.

Schlussfolgerungen Die Lucidis IOL weist ein gutes Sicherheitsprofil mit einer akzeptabel niedrigen Komplikationsrate auf. Während die unkorrigierte visuelle Leistung dieses neuen optischen Designs der von anderen EDOF-IOLs für das Fernsehen unterlegen ist, werden im Zwischen- und Nahbereich bessere Ergebnisse erzielt, wobei die Kontrastempfindlichkeit konstant ist. Interessanterweise waren die selbstberichtete Brillenunabhängigkeit und die subjektive Patientenzufriedenheit über alle Entfernungen hoch.

Key words

cataract - refractive surgery - glaucoma - Lucidis - EDOF - IOL - intraocular lens - extended depth of focus

Schlüsselwörter

Katarakt - refraktive Chirurgie - Glaukom - Intraokularlinse - erweiterte Tiefenschärfe
 

  • References

  • 1 Williams HP. Sir Harold Ridleyʼs vision. Br J Ophthalmol 2001; 85: 1022-1023
    CrossrefPubMedGoogle Scholar
  • 2 Liao X, Lin J, Tian J. et al. Evaluation of Optical Quality: Ocular Scattering and Aberrations in Eyes Implanted with Diffractive Multifocal or Monofocal Intraocular Lenses. Curr Eye Res 2018; 43: 696-701
    CrossrefPubMedGoogle Scholar
  • 3 Pedrotti E, Carones F, Aiello F. et al. Comparative analysis of visual outcomes with 4 intraocular lenses: Monofocal, multifocal, and extended range of vision. J Cataract Refract Surg 2018; 44: 156-167
    CrossrefPubMedGoogle Scholar
  • 4 Yen CT, Jin SC. Aspherical Lens Design Using Genetic Algorithm for Reducing Aberrations in Multifocal Artificial Intraocular Lens. Materials (Basel) 2015; 8: 6309-6325
    CrossrefPubMedGoogle Scholar
  • 5 Alió JL, Kaymak H, Breyer D. et al. Quality of life related variables measured for three multifocal diffractive intraocular lenses: a prospective randomised clinical trial. Clin Exp Ophthalmol 2018; 46: 380-388
    CrossrefPubMedGoogle Scholar
  • 6 Elliott DB, Patla AE, Furniss M. et al. Improvements in clinical and functional vision and quality of life after second eye cataract surgery. Optom Vis Sci 2000; 77: 13-24
    CrossrefPubMedGoogle Scholar
  • 7 Toygar B, Yabas Kiziloglu O, Toygar O. et al. Clinical outcomes of a new diffractive multifocal intraocular lens. Int J Ophthalmol 2017; 10: 1844-1850
    PubMedGoogle Scholar
  • 8 Leyland M, Zinicola E. Multifocal versus monofocal intraocular lenses in cataract surgery: a systematic review. Ophthalmology 2003; 110: 1789-1798
    CrossrefPubMedGoogle Scholar
  • 9 Tan N, Zheng D, Ye J. Comparison of visual performance after implantation of 3 types of intraocular lenses: accommodative, multifocal, and monofocal. Eur J Ophthalmol 2014; 24: 693-698
    CrossrefPubMedGoogle Scholar
  • 10 Swiss Advanced Vision, SAV-IOL SA. Instant Focus IOL: InFo Brochure EN. Neuchâtel, Switzerland: SAV-IOL SA; 2017. Available at http://sav-iol.com/wp-content/uploads/2017/09/Brochure_InFo.pdf Accessed 03.06.2018
    Google Scholar
  • 11 Akella SS, Juthani VV. Extended depth of focus intraocular lenses for presbyopia. Curr Opin Ophthalmol 2018; 29: 318-322
    CrossrefPubMedGoogle Scholar
  • 12 Moshegov CN, Skaf S. Visual outcomes after implantation of a low-add (+ 3.25 D) diffractive multifocal intraocular lens. Clin Exp Ophthalmol 2015; 43: 839-841
    CrossrefPubMedGoogle Scholar
  • 13 Cochener B, Boutillier G, Lamard M. et al. A Comparative Evaluation of a New Generation of Diffractive Trifocal and Extended Depth of Focus Intraocular Lenses. J Refract Surg 2018; 34: 507-514
    CrossrefPubMedGoogle Scholar
  • 14 Rosen E, Alió JL, Dick HB. et al. Efficacy and safety of multifocal intraocular lenses following cataract and refractive lens exchange: Metaanalysis of peer-reviewed publications. J Cataract Refract Surg 2016; 42: 310-328
    CrossrefPubMedGoogle Scholar
  • 15 Hogarty DT, Russell DJ, Ward BM. et al. Comparing visual acuity, range of vision and spectacle independence in the extended range of vision and monofocal intraocular lens. Clin Exp Ophthalmol 2018; 46: 854-860
    CrossrefPubMedGoogle Scholar
  • 16 Swiss Advanced Vision, SAV-IOL SA. Instant Focus IOL. Unpublished data. 2018
    PubMedGoogle Scholar
  • 17 Gatinel D, Loicq J. Clinically Relevant Optical Properties of Bifocal, Trifocal, and Extended Depth of Focus Intraocular Lenses. J Refract Surg 2016; 32: 273-280
    CrossrefPubMedGoogle Scholar
  • 18 Novartis. AcrySof® IQ ReSTOR® + 2.5 D IOL: Directions for Use. Basel, Switzerland: Novartis; 2015: Available at Available at https://www.myalcon.com/products/surgical/docs/ReSTOR-2p5-SA.pdf Accessed 03.06.2018
    Google Scholar
  • 19 Kim JS, Jung JW, Lee JM. et al. Clinical Outcomes Following Implantation of Diffractive Multifocal Intraocular Lenses With Varying Add Powers. Am J Ophthalmol 2015; 160: 702-709.e1
    CrossrefPubMedGoogle Scholar
  • 20 Pomares ES, Plaza-Puche AB, Alió JL. Diffractive Bifocal Intraocular Lens: Acri.Lisa 366D. In: Jorge L, Alió JL, Pikkel J. eds. Multifocal Intraocular Lenses. Historical Perspective. Cham: Springer International Publishing; 2014: 171-179
    Google Scholar
  • 21 Ram J, Pandey SK, Apple DJ. et al. Effect of in-the-bag intraocular lens fixation on the prevention of posterior capsule opacification. J Cataract Refract Surg 2001; 27: 1039-1046
    CrossrefPubMedGoogle Scholar